DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE and EPISTAXIS

Overview

EPISTAXIS is the #13 most commonly reported adverse reaction for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, manufactured by RB Health (US) LLC. There are 5 FDA adverse event reports linking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE to EPISTAXIS. This represents approximately 1.7% of all 298 adverse event reports for this drug.

Patients taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE who experience epistaxis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

EPISTAXIS is a less commonly reported adverse event for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE

In addition to epistaxis, the following adverse reactions have been reported for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE:

• DIZZINESS — 15 reports
• DYSPNOEA — 14 reports
• DRUG INEFFECTIVE — 12 reports
• INSOMNIA — 9 reports
• VOMITING — 9 reports
• NAUSEA — 7 reports
• ANXIETY — 6 reports
• FEELING ABNORMAL — 6 reports
• HEART RATE INCREASED — 6 reports
• NERVOUSNESS — 6 reports

Other Drugs Associated with EPISTAXIS

The following drugs have also been linked to epistaxis in FDA adverse event reports:

Does DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE cause EPISTAXIS?

EPISTAXIS has been reported as an adverse event in 5 FDA reports for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is EPISTAXIS with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE?

EPISTAXIS accounts for approximately 1.7% of all adverse event reports for DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience EPISTAXIS while taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE?

If you experience epistaxis while taking DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages